Ondansetron Tablet, Orally Disintegrating
Product Images NDC 70518-1551

5 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 70518-1551). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical Structure (Ondansetronod Str)
Chemical structure diagram of ondansetron, illustrating its molecular framework including fused rings and side chains, as relevant to the active pharmaceutical ingredient ondansetron.*
FDA Label Image

Mm1 (Ondansetron 8mg 70518 1551 00)

Mm1 (Ondansetron 8mg 70518 1551 00)
Ondansetron 8 mg orally disintegrating tablets label for a 6-tablet package. The label includes the NDC 70518-1551-00 and indicates repackaging by RemedyRepack Inc., Indiana, PA. Manufacturing details note Aurobindo Pharma, Hyderabad, India. Storage instructions and a QR code are also present.*
FDA Label Image

Mm2 (Ondansetron 8mg 70518 1551 01)

Mm2 (Ondansetron 8mg 70518 1551 01)
Ondansetron 8 mg orally disintegrating tablets packaging label showing quantity of 30 tablets. Label includes the National Drug Code (NDC) 70518-1551-01, manufacturing source Aurobindo Pharma, Hyderabad, India, and repackaging information by RemedyRepack Inc. Directions for use refer to the package insert. The label also contains storage instructions and a QR code.*
FDA Label Image

Mm3 (Ondansetron 8mg 70518 1551 02)

Mm3 (Ondansetron 8mg 70518 1551 02)
Ondansetron 8 mg orally disintegrating tablets packaging label showing a quantity of 10 tablets. The label includes NDC number 70518-1551-02 and indicates repackaging by RemedyRepack Inc., Indiana, PA. Manufacturer information for Aurobindo Pharma in Hyderabad, India, is also visible. Storage instructions and a QR code are present on the label.*
FDA Label Image

Mm4 (Ondansetron 8mg 70518 1551 03)

Mm4 (Ondansetron 8mg 70518 1551 03)
Ondansetron 8 mg orally disintegrating tablets label showing quantity of 2 tablets. The label includes the NDC number 70518-1551-03, manufacturer information with Aurobindo Pharma, and repackager Remedy Repack Inc. It features storage instructions and a QR code, designed with purple and white colors.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.